Chemical Industries (Far East) Limited (SGX:C05)
Singapore · Delayed Price · Currency is SGD 0.5500
0.00 (0.00%)
Jun 12, 2026, 1:00 PM SGT
SGX:C05 Income Statement
Financials in millions SGD. Fiscal year is April - March.
Millions SGD. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 60.63 | 65.37 | 72.58 | 100.03 | 85 | |
Revenue Growth (YoY) | -7.25% | -9.93% | -27.44% | 17.69% | 34.92% |
Cost of Revenue | 52.15 | 61.54 | 66.95 | 93.11 | 62.93 |
Gross Profit | 8.49 | 3.84 | 5.63 | 6.93 | 22.07 |
Selling, General & Admin | 10.29 | 10.6 | 11.06 | 12.02 | 14.26 |
Other Operating Expenses | - | - | - | -2.35 | -1.32 |
Operating Expenses | 10.29 | 10.6 | 11.06 | 9.67 | 12.94 |
Operating Income | -1.8 | -6.76 | -5.43 | -2.74 | 9.13 |
Interest Expense | -0.28 | -0.3 | -0.3 | -0.07 | -0.15 |
Interest & Investment Income | - | 0.65 | 0.61 | 0.42 | 0.16 |
Currency Exchange Gain (Loss) | - | -0.44 | -1.03 | -0.29 | 0.01 |
Other Non Operating Income (Expenses) | 1.05 | -4.72 | 1.71 | - | - |
EBT Excluding Unusual Items | -1.03 | -11.58 | -4.43 | -2.67 | 9.15 |
Gain (Loss) on Sale of Investments | - | 0.27 | -0 | -0.06 | 0.12 |
Gain (Loss) on Sale of Assets | - | 0.01 | -0.02 | 0 | - |
Asset Writedown | 0.1 | -10.8 | 9.8 | 6.4 | -3.86 |
Other Unusual Items | - | - | - | 0.39 | 0.41 |
Pretax Income | -0.93 | -22.1 | 5.35 | 4.07 | 5.81 |
Income Tax Expense | -0.01 | -0.65 | 0.48 | 0.51 | -0.99 |
Net Income | -0.92 | -21.46 | 4.87 | 3.55 | 6.8 |
Net Income to Common | -0.92 | -21.46 | 4.87 | 3.55 | 6.8 |
Net Income Growth | - | - | 36.89% | -47.73% | 22.08% |
Shares Outstanding (Basic) | 76 | 76 | 76 | 76 | 76 |
Shares Outstanding (Diluted) | 76 | 76 | 76 | 76 | 76 |
Shares Change (YoY) | 0.01% | - | - | - | - |
EPS (Basic) | -0.01 | -0.28 | 0.06 | 0.05 | 0.09 |
EPS (Diluted) | -0.01 | -0.28 | 0.06 | 0.05 | 0.09 |
EPS Growth | - | - | 36.89% | -47.73% | 22.08% |
Free Cash Flow | 1.63 | 0.52 | -5.91 | -11.88 | 5.35 |
Free Cash Flow Per Share | 0.02 | 0.01 | -0.08 | -0.16 | 0.07 |
Dividend Per Share | 0.005 | 0.005 | 0.015 | 0.015 | 0.015 |
Dividend Growth | - | -66.67% | - | - | - |
Gross Margin | 14.00% | 5.87% | 7.76% | 6.93% | 25.97% |
Operating Margin | -2.96% | -10.34% | -7.48% | -2.74% | 10.74% |
Profit Margin | -1.52% | -32.82% | 6.70% | 3.55% | 8.00% |
Free Cash Flow Margin | 2.69% | 0.79% | -8.15% | -11.88% | 6.30% |
EBITDA | 2.53 | -0.05 | 0.65 | 2.04 | 14.23 |
EBITDA Margin | 4.17% | -0.08% | 0.90% | 2.04% | 16.74% |
D&A For EBITDA | 4.32 | 6.71 | 6.08 | 4.78 | 5.1 |
EBIT | -1.8 | -6.76 | -5.43 | -2.74 | 9.13 |
EBIT Margin | -2.96% | -10.34% | -7.48% | -2.74% | 10.74% |
Effective Tax Rate | - | - | 9.03% | 12.59% | - |